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ABSTRACT 1 
Bacteriological diagnosis of brucellosis is performed by culturing animal samples directly on 2 
both Farrell (FM) and a modified Thayer-Martin (mTM) media. However, despite inhibiting most 3 
contaminating microorganisms, the FM also inhibits the growth of B. ovis and some B. 4 
melitensis and B. abortus strains. On the contrary, the mTM is adequate for all Brucella 5 
species but only partially inhibitory for contaminants. Moreover, the performance of both 6 
culture media for isolating B. suis has never been established properly. We first determined the 7 
performance of both media for B. suis isolation, proving that FM inhibited significantly B. suis 8 
growth. We determined also the susceptibility of B. suis to the antibiotics contained in both 9 
selective media, proving that Nalidixic Acid and Bacitracin were highly inhibitory, thus 10 
explaining the reduced performance of FM for B. suis isolation. Based on these results, a new 11 
selective medium (CITA) containing Vancomycin, Colistin, Nystatin, Nitrofurantoin and 12 
Amphotericin B, was tested for isolating the main Brucella species including B. suis. CITA 13 
performance was evaluated using reference contaminant strains but also field samples taken 14 
from brucellosis infected or suspected animals. CITA inhibited most of contaminant 15 
microorganisms but allowed the growth of all Brucella species at similar levels than did both 16 
the control medium without antibiotics and the mTM. Moreover, CITA medium was more 17 
sensitive than both mTM and FM for isolating all Brucella species from field samples. 18 
Altogether, these results demonstrate the adequate performance of CITA medium for the 19 
primary isolation of the main Brucella species including B. suis.  20 
INTRODUCTION 1 
Brucellosis is a worldwide spread zoonosis affecting mainly to low income countries (23). 2 
Besides the two new species (Brucella ceti and B. pinnipedialis) isolated recently from marine 3 
mammals, the genus Brucella includes six classical species named according to their host 4 
preference (19). From them, B. melitensis, B. abortus, B. suis, and B. ovis (which infect 5 
preferentially sheep and goats, cattle, pigs, and sheep, respectively) are the most important 6 
from the socio-economic standpoint, since in addition to decreasing productivity in animals, the 7 
first three species are the main responsible of brucellosis in human beings (20). In infected 8 
animals, brucellae can be isolated in live animals from vaginal discharges, placental and foetal 9 
tissues, milk, semen, and after necropsy, from lymph nodes, spleen, liver, mammary glands, 10 
epididymides and male sexual glands. Due to its specificity, the isolation and identification of 11 
Brucella in these animal fluids and tissues is the only incontestable demonstration of 12 
brucellosis in a given animal or flock. Since Brucella primary isolation requires 4-7 days of 13 
incubation, the presence in the above field samples of overgrowing fungi as well as 14 
commensal and environmental bacteria explains the frequent contamination of culture plates, 15 
and the reduced sensitivity of bacteriological diagnosis. Thus, the use of adequate selective 16 
culture media is of paramount importance for a proper bacteriological diagnosis of brucellosis.  17 
The simultaneous use of Farrell’s (FM; 7) and a modified Thayer-Martin's (mTM; 16) 18 
culture media is currently considered the strategy of choice for Brucella primary isolation from 19 
field veterinary samples (21). The FM is probably the most widely used selective medium for 20 
the bacteriological diagnosis of brucellosis. This excellent medium, initially developed for the 21 
isolation of B. abortus biovar 2 from contaminated sources (6; 7), contains antibiotics that are 22 
highly inhibitory for most overgrowing contaminants present in field veterinary samples (15). 23 
Moreover, as it is translucent, it facilitates the presumptive identification of Brucella by 24 
assessing the colonial morphology (1). However, due mainly to the Nalidixic Acid and 25 
Bacitracin contained in its formulation, this FM is inhibitory for B. ovis and also for some B. 26 
melitensis and B. abortus strains (16). Having in consideration that the mTM improves 27 
significantly the sensitivity of the FM for the isolation of B. ovis and B. melitensis (3; 15), the 28 
simultaneous use of both culture media has been recommended for the routine bacteriological 29 
diagnosis of disease (OIE 2009). However, the mTM is significantly less inhibitory than the FM 1 
for contaminant microorganisms. Moreover, the mTM is not translucent due to the presence of 2 
haemoglobin as a basal component, being thus unsuitable for direct observation of colonial 3 
morphology, probably the most practical procedure for the presumptive identification of 4 
Brucella (1). Finally, the performance of both FM and mTM media for isolating B. suis has 5 
been the object of debate, but never investigated thoroughly. One of the objectives of this work 6 
was to evaluate this, and investigate the susceptibility of B. suis to the different antibiotics 7 
contained in both selective media. Having in consideration the results obtained, we have 8 
formulated a new selective culture medium (named herein CITA) which, in addition to being 9 
translucent, allows the growth of all Brucella species and, simultaneously, inhibits most of 10 
contaminant microorganisms usually present in veterinary samples.   11 
 12 
MATERIAL AND METHODS 13 
1. Bacterial strains, growth conditions and media composition. The Brucella 14 
reference and field strains used are summarized in Table 1. All Brucella strains were typed by 15 
standard bacteriological (1), and molecular (8) procedures, and kept lyophilised at 4ºC in the 16 
culture collection of the CITA de Aragón (Zaragoza, Spain) until use. After rehydratation, the 17 
strains were cultured on Blood Agar Base plates (BAB Nº2; Biolife, Italy) supplemented with 18 
5% of sterile newborn calf serum (CS; PanBiotech, Germany) (BAB-CS), as described 19 
previously (9). Brucella suspensions were prepared by spectrophotometry (suspensions with 20 
OD600nm readings of 0.170 contain usually 1×109 CFU/mL) in sterile buffered saline solution 21 
(BSS; pH 6.85), and adjusted to the desired concentration in BSS or Mueller-Hinton Broth 22 
(MHB; Difco, USA) supplemented with 0.5% Yeast Extract (YE; Difco, USA) and 5% CS (MHB-23 
YE-CS). The exact number of colonies (CFU/mL) contained in each bacterial suspension was 24 
determined retrospectively, as described elsewhere (9).  25 
The microorganisms used as typical contaminants of veterinary samples were: 26 
Escherichia coli (ATCC285922), Staphylococcus aureus (ATCC6538), Aspergillus niger 27 
(ATCC16404), Bacillus subtilis (ATCC6633), Enterococcus faecalis (ATCC29212), 28 
Pseudomonas aeruginosa (ATCC27853), and Proteus spp (MicroBioLogics). All these strains 29 
were provided by the Spanish Type Culture Collection (ECCT; University of Valencia, Spain) 1 
and cultured as recommended by the supplier. The growth/inhibition of these contaminant 2 
microorganisms onto the corresponding selective culture media was assessed after one week 3 
of incubation at 37ºC in both air and 10% CO2 atmospheres.  4 
Both FM and mTM selective culture media were prepared as described previously (16) 5 
and the composition of these media is shown in Table 2.  6 
2. Susceptibility of B. suis to both FM and mTM culture media. Bacterial suspensions 7 
from the 5 B. suis reference and 40 field strains tested (Table 1) were prepared in BSS, and 8 
dilutions containing around 1×103 CFU/mL were cultured (0.1 mL/plate) by triplicate on plates 9 
of FM, mTM and BAB-CS (as control).  The mean and SD of CFU/plate was determined for 10 
each strain in each culture medium after incubation of plates at 37ºC for 3 days in 10% CO2 11 
atmosphere. In addition, these 40 B. suis field strains were also studied for individual 12 
susceptibility to each of the 9 antimicrobial agents contained in both FM and mTM media, as 13 
well as to Amphotericin B (Sigma Aldrich, USA) (see Table 2). This experiment was carried 14 
out, in both liquid and solid media as follows:  15 
2.1. Liquid medium assay. Bacterial suspensions in MHB-YE-CS of the above-16 
mentioned B. suis strains were adjusted to 5×105 CFU/mL as above, and 0.1 mL of each 17 
suspension mixed in 96-well sterile plates (Nunc® microplates, ThermoFisher Scientific S.L.U., 18 
Spain) with 0.1 mL of MHB-YE-CS supplemented with the adequate antibiotic concentrations. 19 
For this, concentrated suspensions of each antibiotic were prepared in MHB-YE-CS (40 mg/L 20 
Nalidixic Acid, 200,000 IU/L Bacitracin, 40,000 IU/L Polymyxin B, 800 mg/L Cycloheximide, 21 
400 mg/L Natamycin, 800,000 IU/L Nystatin, 160 mg/L Vancomycin, 60 mg/L Colistin, 80 22 
mg/mL Nitrofurantoin, and 32 mg/L of Amphotericin B) (all from Sigma Aldrich, USA ) and then, 23 
serially two-fold diluted in MHB-YE-CS. Wells containing only bacteria, antibiotics or MHB-YE-24 
CS were used as controls in each plate. Plates were incubated at 37º C in 10% CO2, and 25 
bacterial growth spectrophotometrically determined (OD595nm readings) at 4 and 7 days after 26 
incubation, and confirmed by streaking out 25 µL/well by triplicate onto BAB-CS plates that 27 
were incubated at 37ºC in 10% CO2 for 5-7 days. Isolation of at least one CFU was considered 28 
as a positive result.  29 
2.2. Solid medium assay. Bacterial suspensions of the above-mentioned B. suis strains 1 
tested were adjusted in BSS to 1×103 CFU/mL, and 0.1 mL of the corresponding suspensions 2 
smeared by triplicate on MH plates (MHA; Difco, USA) supplemented with YE-CS as above 3 
(MHA-YE-CS), and added or not with the corresponding concentrations of each antibiotic 4 
(Table 2). Nalidixic Acid and Bacitracin (both from Sigma Aldrich, USA) were also tested at 5 
two-fold concentrations above of that contained in FM. The mean number of CFU/plate for 6 
each culture medium was determined after incubation at 37ºC for 5-7 days in a 10% CO2 7 
atmosphere. The mean (n=3) of individual number of CFU/plate was assessed for each 8 
Brucella strain in each culture medium. Once assessed that an equivalent number of CFU was 9 
obtained in the control BAB-CS medium for the 45 B. suis strains tested, the mean and SD of 10 
CFU/plate was determined for each antimicrobial agent. Statistical comparisons of means 11 
were performed by a two-way (strain-medium interaction) ANOVA followed by post-hoc 12 
Fisher’s Protected Least Significant Differences test.  13 
3. Development of a new selective culture medium (CITA).  14 
Having in consideration the importance and practical interest of using translucent media, 15 
the performance of the following basal culture media was assessed for isolating the main 16 
Brucella species: Brucella Medium Base (BMB; Oxoid, UK), GC medium base (GC; Difco, 17 
USA), Tripticase Soy broth supplemented with 0.5% Yeast Extract (both products from Biolife, 18 
Italy) and 1.5% of Agar (Difco, USA) (TSA-YE), and BAB. All these basal components were 19 
supplemented with 5% of sterile CS, and the resulting culture media (BMB-CS, GC-CS, TSA-20 
YE-CS, and BAB-CS) compared for Brucella growth. Adjusted suspensions (see above) of 21 
representative B. abortus, B. melitensis, B. suis, and B. ovis strains (Table 1) were plated in 22 
the corresponding basal medium and incubated for 5-7 days at 37ºC in 10% CO2, and the 23 
resulting mean CFU/plate determined as described elsewhere (9). With the exception of GC-24 
CS, which resulted somewhat inhibitory, the remaining media performed similarly for isolating 25 
all Brucella species (results not shown). Having in consideration its adequate performance and 26 
availability, the BAB-CS was considered the basal component of choice for ensuing 27 
experiments. 28 
In a second experimental phase, suspensions of representative Brucella strains (Table 1) 1 
and contaminants were inoculated on BAB-CS plates supplemented with all the antibiotics 2 
contained in the mTM (Table 2) but increasing Vancomycin (Sigma Aldrich, USA ) to 20 mg/L 3 
(as contained in the FM), and adding several concentrations (2.5, 4 or 5 mg/L) of Amphotericin 4 
B (Sigma Aldrich, USA), as a complementary antifungal agent. The same mTM medium 5 
without Amphotericin B (Sigma Aldrich, USA) and the BAB-CS alone were used as controls of 6 
this experiment. The resulting CFU of the corresponding contaminants and brucellae were 7 
determined in triplicate experiments after incubation at 37ºC in 10% CO2 for 3 and 5 days, 8 
respectively. 9 
According to the results obtained in these previous experiments, 4 mg/L of Amphotericin 10 
B (Sigma Aldrich, USA) and 20 mg/L of Vancomycin (Sigma Aldrich, USA) were considered 11 
adequate enough for inhibiting the contaminant microorganisms while allowing the growth of all 12 
Brucella species and strains tested. Thus, the CITA medium was formulated with BAB-CS as a 13 
basal component, and with the following antibiotic supplements: Vancomycin (20 mg/L), 14 
Colistin methanesulfonate (7.5 mg/L), Nitrofurantoin (10 mg/L), Nystatin (100,000 IU/L), and 15 
Amphotericin B (4 mg/L) (all from Sigma Aldrich, USA). 16 
4. Diagnostic performance of CITA medium.  17 
The performance of this new selective culture medium was compared with that of both 18 
FM and mTM, using representative reference and field strains (i.e. 38 B. abortus, 35 B. 19 
melitensis, 45 B. suis, and 34 B. ovis). Adequate suspensions of these strains were cultured by 20 
triplicate, and the number of CFU per plate in each selective medium and in BAB-CS as 21 
control was determined and statistically compared as described previously (Grilló et al 2006). 22 
Also, the growth/inhibition of contaminant microorganisms was determined in each culture 23 
medium after 72 hours of incubation at 37ºC in 10% CO2 atmosphere. 24 
In a final step, the performance of CITA medium for direct primary isolation was 25 
compared to that of FM and mTM, the last being supplemented with 4 mg/L of Amphotericin B 26 
(Sigma Aldrich, USA) (mTMA). For this, a total of 4,483 fresh field samples were obtained 27 
either in vivo (milk, vaginal swabs, semen) or after necropsy (uterus/epididymides, spleen and 28 
lymph nodes) from: i) rams experimentally infected with B. ovis PA (n= 528 samples); ii) sheep 29 
suspected from B. melitensis infection (n= 3,247 samples); iii) swine suspected from B. suis 1 
infection (n= 602 samples); and iv) aborted cattle living in a B. abortus endemic area and 2 
vaccinated with B. abortus RB51 (n= 106 samples) (Table 4). All these samples were taken 3 
and processed as described previously (2), and the same sample amounts (massively in the 4 
case of vaginal swabs and 0.5 mL of tissue homogenate/plate in the remaining samples) were 5 
cultured in duplicate plates of CITA and either mTMA or FM culture media (Table 4). One 6 
culture was considered as positive when at least one CFU of Brucella was isolated. The 7 
suspected Brucella colonies isolated were identified and typed using both standard 8 
microbiological (1) and molecular methods (8). The number of contaminated plates of each 9 
selective medium was also recorded.  10 
 11 
RESULTS 12 
1. B. suis studies. The mean and SD (n=45) of CFU/plate obtained with representative 13 
B. suis strains in FM (11.3 ± 5.7) was significantly lower (P<0.0001) than that obtained in both 14 
the mTM (69.4 ± 21) and BAB-CS (69.3 ± 20) media. The liquid medium assay evidenced that 15 
all B. suis strains were highly susceptible to Nalidixic Acid and Bacitracin at concentrations 16 
close to and above that contained in the FM (data not shown). These results correlated with 17 
those obtained in the solid medium assays (Table 3), in which the number of B. suis CFU was 18 
significantly inhibited (P<0.001) by both antibiotics at the concentrations used in FM and at 19 
twofold upper concentrations (Table 3). By contrast, the remaining antibiotics tested did not 20 
show significant inhibitory effects for B. suis.  21 
2. Development and performance of the CITA selective medium. 22 
B. suis biovar 2 strains were significantly (P<0.0001) inhibited when cultured on GC-CS 23 
basal medium (not shown). However, when haemoglobin was added to this basal medium, all 24 
B. suis strains grew as in BAB-CS (not shown). Although not significantly, the BMB-CS basal 25 
medium was affecting negatively the growth of B. ovis (not shown). Thus, both media were 26 
discarded as basal components for formulating the new CITA medium. In contrast, both BAB-27 
CS and TSA-YE-CS media showed similar performance (in terms of CFU numbers, and 28 
colonial morphology and size) for supporting the growth of all Brucella species (not shown). 1 
For practical reasons, availability and easier preparation, the BAB-CS was selected as the 2 
basal medium for CITA formulation. 3 
The antibiotics contained in the mTM (Table 2) allowed the growth of A. niger and E. 4 
faecalis, while inhibiting the remaining contaminant microorganisms tested (not shown). 5 
However, A. niger was inhibited when 4 or 5 mg/L (but not 2.5 mg/L) of Amphotericin B were 6 
added to either mTM or BAB-CS media (not shown). Moreover E. faecalis growth was fully 7 
inhibited when 20 mg/L (but not lower concentrations) of Vancomycin were added to either the 8 
mTM or BAB-CS media. Therefore, in addition to the antibiotics contained in the mTM (Table 9 
2), Amphotericin B (4 mg/L) and Vancomycin (20 mg/L) were selected as the antibiotic 10 
combination of choice for the definitive formulation of the new CITA selective medium. 11 
The comparative efficacy of the mTM, FM and CITA media to support the growth of the 12 
different Brucella species and biovars is shown as box-plot graph in Figure 1. Boxes represent 13 
the two central quartiles, between whiskers are the 90% of data obtained for each Brucella 14 
species (Table 1) in each culture medium, and lanes inside boxes indicate the median values 15 
of CFU/plate obtained. As expected, the FM fully inhibited the growth of B. ovis and reduced 16 
significantly the growth of B. suis and B. melitensis (P<0.0001), as well as of some strains of B. 17 
abortus (not evident in Figure 1) respect to BAB-CS control medium. Moreover, both CITA and 18 
mTM selective media were as effective as the BAB-CS medium without added antibiotics for 19 
supporting the growth of all Brucella species and biovars tested (Figure 1). When testing the 20 
ability of these culture media for inhibiting the growth of contaminants, both FM and CITA 21 
media fully inhibited the standard contaminant microorganisms tested, while the mTM was 22 
allowing the growth of A. niger and E. faecalis (results not shown).  23 
The comparative diagnostic performance of the three selective culture media for isolating 24 
Brucella from field samples is summarised in Table 4. The number of culture plates discarded 25 
due to the presence of overgrowing contaminants was lower in CITA than in mTM when 26 
culturing samples from B. ovis exposed rams, but similar to that of FM when culturing the 27 
remaining samples. No matter the Brucella species considered, the new CITA medium showed 28 
a better overall diagnostic sensitivity than the other selective media compared (Table 4). 29 
 1 
DISCUSSION 2 
The use of selective culture media is needed to increase the probability of success, and it 3 
is compulsory for the adequate bacteriological diagnosis of brucellosis. The different studies 4 
conducted with the several selective culture media described until now (1, 3, 5, 7, 10, 11, 12, 5 
13, 15, 17, 22, 24, 25, 26, 27) conclude that the simultaneous use of both FM and mTM results 6 
in maximal sensitivity to isolate the most relevant Brucella species and biovars from field 7 
veterinary samples (21). The FM is probably the most widely used selective medium for 8 
isolating Brucella, because inhibits most of contaminants usually present in field veterinary 9 
samples. However, some of the antibiotics contained in this medium result also highly 10 
inhibitory for B. ovis and some B. melitensis and B. abortus strains, including the RB51 vaccine 11 
strain (11, 16). In the case of B. abortus and B. melitensis, this inhibitory effect is mainly due to 12 
the presence in FM of Nalidixic Acid and Bacitracin at concentrations (Table 3) close or higher 13 
than those allowing the growth of all strains from these Brucella species (16). The results 14 
obtained here confirm the above findings, showing that FM fully inhibits the growth of B. ovis 15 
and reduces significantly the growth of B. melitensis, and moreover, demonstrate that it is also 16 
highly inhibitory for B. suis (Figure 1). Despite a somewhat reduced growth of B. abortus in the 17 
FM (Figure 1), the differences obtained were not statistically significant in this study.  18 
As indicated above, the FM is the preferred culture medium for the primary isolation of B. 19 
abortus from contaminated sources. Due to the presence of calf serum (7), this medium is very 20 
effective for isolating serum-dependent strains from B. abortus biovar 2 (6; 7). The presence of 21 
Cycloheximide in the antibiotic supplement makes this medium highly effective for inhibiting 22 
the growth of fungi, which are one of the main contaminants found in field veterinary samples. 23 
This agent inhibits the translation of messenger RNA by ribosomes, preventing protein 24 
synthesis of fungi. However, this drug has potentially toxic effects for mammalian cells, 25 
including teratogenesis, DNA damage, birth defects, sperm toxicity, and several others (14). 26 
The existence of these risks has resulted in the increasingly reduced availability and use of 27 
Cycloheximide in the past recent years. Natamycin has been proposed as an alternative to 28 
Cycloheximide to be included in the commercially available antibiotic supplements for Brucella 29 
selective media (26). In fact, an antibiotic supplement containing Natamycin is now currently 1 
available (Oxoid reference SR209A), although it has been reported that this drug is somewhat 2 
less inhibitory than Cycloheximide for fungal growth (26). Amphotericin B has been proposed 3 
as a safer and cheaper antifungal agent, and recommended as a component of culture media 4 
for the primary isolation of Mycobacterium spp. (4) and Campylobacter spp (18). This drug 5 
interacts with ergosterol, a steroid present in fungal membranes, and results in a loss of both 6 
membrane-selective permeability and cytoplasmic components. However, Amphotericin B 7 
does not affect bacteria, with the exception of Mycoplasma species. As demonstrated here, 8 
when used at 4 mg/L, Amphotericin B was inhibitory for the reference fungal contaminants 9 
tested but did not affect the growth of B. suis (Table 3) nor the remaining Brucella species 10 
tested, when incorporated in the new CITA formulation (Figure 1). 11 
Altogether, the results of the different experiments conducted allowed us to select the 12 
most adequate components for formulating a new selective medium (CITA) suitable for the 13 
isolation of all Brucella species. In addition to a suitable antibiotic combination (Table 2), this 14 
new medium contains blood agar base and serum (BAB-CS) as basal components, which 15 
result in a translucent medium, being this of importance to facilitate the presumptive 16 
identification of brucellae by assessing colonial morphology under stereoscopic magnification 17 
(1). The addition of serum is also of relevance since this component allows the growth of the 18 
most fastidious Brucella strains, including B. ovis. These components of the CITA medium 19 
were proven highly effective in the final experiment assessing its diagnostic performance using 20 
a large collection of animal field samples (Table 4).  21 
Both FM and mTM have been reported as highly inhibitory for B. abortus RB51 vaccine 22 
strain (11, 10). Our results agree with these reports since the FM was inhibiting over the half of 23 
B. abortus strains isolated, most of which were RB51 (Table 4). In conclusion, the new CITA 24 
selective culture medium should be considered as a useful tool for successful isolation of all 25 
Brucella species from field veterinary samples. However, the simultaneous use of CITA plus 26 
FM or mTMA results in the best diagnostic performance for isolating, respectively, B. 27 
melitensis and B. suis or B. ovis. 28 
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Legend to figure 16 
Figure 1: Growth (number of CFU/plate) of the representative Brucella species (see Table 1 17 
for description) on BAB-CS (Blood Agar Base number 2 (Biolife, Italy) supplemented with 5% 18 
of sterile calf serum (CS; PanBiotech, Germany) and three selective culture media: mTM 19 
(modified Thayer-Martin; Marín et al 1996b); FM (Farrell; Marín et al 1996b); and CITA (the 20 
new selective medium developed in this work). Statistical comparisons of means (number of 21 
CFU/plate) obtained for a given Brucella spp, in each culture medium were performed by 22 
Fisher’s PLSD test: *P<0.0001 between FM and whatever culture media. 23 
Table 1. Brucella reference and field strains used in this work. 
Brucella reference strains  Brucella strains isolated from field samples 
specie biovar strain  specie biovar               number of strains 
B. abortus 1 2308  B. abortus 1 (S19) 2 
 1 S19   1 (RB51) 26 
 3 Tulya   3 7 
B. melitensis 1 16M  B. melitensis 1 61 
 1 Rev1   3 148 
 2 63/9   1 (Rev1) 28 
 3 Ether     
B. suis 1 1330  B. suis 1 5 
 2 Thomsen   2 25 
 3 680   3 7 
 4 40   4 3 
 5 513     
B. ovis N.A. Bow  B. ovis N.A. 32 
 N.A. Reo 198     
B. canis N.A. 6/66     
N.A. Not applicable.  
Table 2: Composition of the selective culture media compared. 
 
Composition FM mTM CITA 
Basal medium BMB-CS GC-H BAB-CS 
Nalidixic Acid (mg/L) 5 --- --- 
Bacitracin (IU/L) 25,000 --- --- 
Polymyxin B (IU/L) 5,000 --- --- 
Cicloheximide (mg/L) 100 --- --- 
Natamycin (mg/L) 50 --- --- 
Vancomycin (mg/L) 20 3 20 
Nystatin (IU/L) 100,000 100,000 100,000 
Colistin (mg/L) --- 7.5 7.5 
Nitrofurantoin (mg/L) --- 10 10 
Amphotericin B (mg/L) --- --- 4 
 
FM: Farrell’s medium (7); BMB-CS: Brucella Medium Base 
(Oxoid, UK) supplemented with 5% sterile calf serum (CS; 
PanBiotech, Germany); this FM is prepared using the 
commercial antibiotic supplements containing either 
Natamycin or Cycloheximide (ref. SR209E and SR0083A, 
respectively; Oxoid, UK); mTM: modified Thayer-Matin’s 
medium (Marín et al., 1996b); GC-H: GC agar base 
supplemented with 2 g Bacto Agar and 1% of haemoglobin (all 
from Difco, USA); CITA: new selective culture medium; BAB-
CS: Blood Agar Base number 2 (Biolife, Italy) supplemented 
with 5% CS; all antimicrobial agents not included in the 
commercial FM supplements were from Sigma, USA. 
 
Table 3: Susceptibility of B. suis to the different antibiotics 
contained in the FM and mTM selective media 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Growth (number of CFU/plate) of 40 representative B. suis 
strains (see Table 1) in MHA-YE-CS supplemented with the 
corresponding antibiotics, at the concentrations used in FM or 
mTM. Nalidixic acid and Bacitracin were also tested at twofold 
upper concentrations to those in FM or mTM. *P<0.001, and 
**P<0.0001 with respect to MHA-YE-CS agar control plates 
without the corresponding antibiotic 
 
Antibiotic Concentration CFU/plate (mean ± SD)a 
5 mg/L 71.7 ± 8.1* Nalidixic acid  
10 mg/L 
    2.9 ± 0.6** 
25,000 IU/L 70.9 ± 6.9* Bacitracin 
50,000 IU/L 
  13.8 ± 3.7** 
Polymyxin B 5,000 IU/L 81.4 ± 7.9 
Cycloheximide 100 mg/L 80.8 ± 7.5 
Natamycin 50 mg/L 78.8 ± 7.3 
Vancomycin 20 mg/L 74.3 ± 9.8 
Nystatin 100,000 IU/L 80.1 ± 7.7 
Colistin 7.5 mg/L 79.6 ± 7.9 
Nitrofurantoin 10 mg/L 80.7 ± 8.1 
Amphotericin B 4 mg/L 80.7 ± 6.6 
None (control) --- 80.5 ± 7.8 
Table 4: Animal samples cultured in CITA and either FM or m-TMA media and the corresponding 
Brucella spp. strains isolated.  
 
aSee Table 2 for exact composition of each selective culture medium. mTMA: mTM supplemented with 
4 mg/L of Amphotericin B; bsemen and necropsy samples from rams experimentally infected with B. 
ovis PA; cvaginal swabs, milk and necropsy samples from sheep suspected from B. melitensis infection; 
dvaginal swabs, milk and necropsy samples from swine suspected from B. suis infection; evaginal 
swabs and milk samples of cattle from B. abortus endemic areas and vaccinated with RB51; N.D.: not 
determined.  
 
No. of Brucella strains isolated [contaminated plates in 
brackets] in: 
No. of samples 
cultured 
CITAa  
alone 
FM 
alone 
mTMA 
alone 
Both media 
compared 
TOTAL 
Brucella species and 
biovar/strain (no. isolates)  
528 b 93 [0] N.D. 50 [22] 151 [10] 294 [32] B. ovis 
3,247 c 157 [37] 39 [45] N.D. 302 [19] 498 [101] B. melitensis bv 1: Rev1 
(28); field strains (331) and 
bv 3 (139) 
602 d 46 [22] 16 [14] N.D. 49 [11] 111 [47] B. suis bv 2  
106 e 11 [21] 0 [13] N.D. 21 [10] 32 [44] B. abortus bv 1: S19 (1), 
RB51 (24) and bv 3 (7)  
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